Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Gene Curbs Coffee Urge, Study Finds

By University of Edinburgh | August 26, 2016

Researchers have identified a gene that appears to curb coffee consumption.

People with a DNA variation in a gene called PDSS2 tend to drink fewer cups of coffee, the study found.

Experts say the findings suggest that the gene reduces the ability of cells to breakdown caffeine, causing it to stay in the body for longer.

This means that a person would not need to consume as much coffee to get the same caffeine hit, the team says.

The findings add to previous studies that have identified genes linked to coffee habits and shed new light on the biological mechanisms of caffeine metabolism.

Researchers looked at genetic information from 370 people living in a small village in south Italy and 843 people from six villages in north-east Italy.

Each of the study participants was asked to complete a survey that included a question about how many cups of coffee they drank each day.

The team found that people with the DNA variation in PDSS2 tended to consume fewer cups of coffee than people without the variation. The effect was equivalent to around one fewer cup of coffee per day on average.

The researchers replicated the study in a group of 1731 people from the Netherlands.  The result was similar but the effect of the gene on the number of cups of coffee consumed was slightly lower.

This could be because of the different styles of coffee that are drunk in the two countries, the researchers say.

In Italy, people tend to drink smaller cups such as espresso whereas in the Netherlands the preference is towards larger cups that contain more caffeine overall.

The study was conducted at the Universities of Edinburgh and Trieste, the Burlo Garofolo Pediatric Institute in Italy, the Erasmus Medical Center and PolyOmica, a data analysis company based in Groningen, the Netherlands.

Researchers from the Italian coffee company Illy also participated in the project though the company did not offer financial support. The study is published in the journal Scientific Reports.


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE